DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cabergoline (Cabergoline) - Headache - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Headache (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cabergoline where reactions include headache. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cabergoline side effects in 35 year old female

Reported by a consumer/non-health professional from Colombia on 2012-08-13

Patient: 35 year old female

Reactions: Vomiting, Nausea, Drug Ineffective, Brain Oedema, Dizziness, Headache

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg, unk
    Indication: Blood Prolactin Increased
    Start date: 2008-01-01

Dostinex
    Dosage: 4 tablets of 0.5 mg inter-day
    Administration route: Oral

Dostinex
    Dosage: 2 tablets of 0.5 mg inter-day
    Administration route: Oral
    Indication: Blood Prolactin Increased
    Start date: 2008-01-01

Other drugs received by patient: Estrogens; Calcium



Possible Cabergoline side effects in 56 year old male

Reported by a physician from Spain on 2012-04-26

Patient: 56 year old male

Reactions: Vomiting, Urinary Incontinence, Coma Scale Abnormal, Headache, Hemiparesis, Pneumocephalus, Dysstasia, Musculoskeletal Stiffness, Depressed Level of Consciousness, Bone Disorder, Intracranial Pressure Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 16 year old male

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2011-11-18

Patient: 16 year old male

Reactions: Haemorrhage, Headache, Hemianopia Heteronymous

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2011-11-18

Patient: 31 year old male

Reactions: Drug Ineffective, Visual Impairment, Neoplasm Progression, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 50 year old male

Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Back Pain, Pupillary Reflex Impaired, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Areflexia, Cortisol Free Urine Increased, Memory Impairment, Anosmia, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg, twice a week
    Administration route: Oral

Metyrapone
    Dosage: 250 mg, bid
    Administration route: Oral

Octreotide Acetate
    Dosage: 300 ug, tid

Octreotide Acetate
    Dosage: 300 ug, tid
    Indication: Blood Corticotrophin Increased

Other drugs received by patient: Rosiglitazone; Capecitabine; Cisplatin; Temozolomide; Etoposide



Possible Cabergoline side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 50 year old male

Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Pupillary Reflex Impaired, Back Pain, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Cortisol Free Urine Increased, Areflexia, Memory Impairment, Anosmia, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg, twice a week
    Administration route: Oral

Metyrapone
    Dosage: 250 mg, bid
    Administration route: Oral

Octreotide Acetate
    Dosage: 300 ug, tid

Octreotide Acetate
    Dosage: 300 ug, tid
    Indication: Blood Corticotrophin Increased

Other drugs received by patient: Capecitabine; Temozolomide; Cisplatin; Etoposide; Rosiglitazone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017